Total submissions: 14
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000233898 | SCV000290281 | likely benign | Adams-Oliver syndrome 5 | 2024-01-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000121690 | SCV000731088 | benign | not specified | 2017-05-04 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000769596 | SCV000738393 | benign | Familial thoracic aortic aneurysm and aortic dissection | 2015-08-11 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769596 | SCV000900993 | likely benign | Familial thoracic aortic aneurysm and aortic dissection | 2016-11-30 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000233898 | SCV002554356 | benign | Adams-Oliver syndrome 5 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV002269861 | SCV002554357 | benign | Aortic valve disease 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002492435 | SCV002798802 | benign | Aortic valve disease 1; Adams-Oliver syndrome 5 | 2021-07-02 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121690 | SCV004029573 | likely benign | not specified | 2023-07-21 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003430679 | SCV004162009 | benign | not provided | 2022-12-01 | criteria provided, single submitter | clinical testing | NOTCH1: PP2, BP4, BS1, BS2 |
ARUP Laboratories, |
RCV003430679 | SCV004563088 | likely benign | not provided | 2023-11-06 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121690 | SCV000085888 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Genome Diagnostics Laboratory, |
RCV000121690 | SCV001807433 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000121690 | SCV001928989 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000121690 | SCV001964547 | benign | not specified | no assertion criteria provided | clinical testing |